We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

A Landmark Study Demonstrates that ‘Complexes Matter’ in How Epigenetic Inhibitors Interact with Their Drug Targets

News   Jan 24, 2011

 
A Landmark Study Demonstrates that ‘Complexes Matter’ in How Epigenetic Inhibitors Interact with Their Drug Targets
 
 
 

RELATED ARTICLES

Protein Switches Sides in Leukemia

News

Researchers have discovered that an epigenetic protein called EZH2 delays the development of acute myeloid leukemia (AML) but then switches sides once the disease is established to help maintain tumor growth.

READ MORE

Device Would Allow TB Dosing to Switch From Daily to Monthly

News

A drug delivery device is under development, which works by slowly releasing antibiotics directly into the patient's stomach. This would allow patients to switch from daily to monthly doses, reducing the burden of tuberculosis treatment.

READ MORE

Cells Remember Gene Repression

News

Epigenetic memory of transcriptional gene silencing has been observed in several organisms. However, it was not known whether mechanisms exist that convey transgenerational memory of a silencing “experience”, without silencing the gene permanently. Researchers have now found such a phenomenon in a unicellular organism.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE